I'm upgrading SelectQuote to a buy rating after the stock's recent sharp fall. The federal government recently approved a 5.06% reimbursement rate increase for Medicare Advantage plans, which should translate into more aggressive marketing from carriers. This will lead to stronger demand and referral fees for SelectQuote, similar to how the government's premium increase approvals helped EverQuote in the auto insurance industry.
The average of price targets set by Wall Street analysts indicates a potential upside of 33.5% in SelectQuote (SLQT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
SelectQuote, Inc. (NYSE:SLQT ) Q2 2025 Results Conference Call February 10, 2025 5:00 PM ET Company Participants Matt Gunter - Investor Relations Tim Danker - Chief Executive Officer Ryan Clement - Chief Financial Officer Bob Grant - President Conference Call Participants Benjamin Hendrix - RBC Capital Markets George Sutton - Craig Hallum Pat McCann - NOBLE Capital Markets Operator Good afternoon, ladies and gentlemen, and thank you for standing by. My name is Kelvin, and I will be your conference operator today.
SelectQuote (SLQT) came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.11 per share a year ago.
SelectQuote, Inc. (NYSE:SLQT ) Q1 2025 Earnings Conference Call November 4, 2024 8:30 AM ET Company Participants Matt Gunter - Investor Relations Tim Danker - Chief Executive Officer Ryan Clement - Chief Financial Officer Bob Grant - President Bill Grant - Chief Operating Officer Conference Call Participants Ben Hendrix - RBC Capital Markets George Sutton - Craig-Hallum Pat McCann - NOBLE Capital Markets Operator Welcome to SelectQuote's First Quarter Earnings [Technical Difficulty]. All lines have been placed on mute to prevent any background noise.
It might be surprising for some to hear that 2024 has been a great year for stocks in the insurance industry. In fact, every single large-cap insurance stock in the United States and Canada trading region has a positive return this year.
It might be surprising for some to hear that 2024 has been a great year for stocks in the insurance industry. In fact, every single large-cap insurance stock in the United States and Canada trading region has a positive return this year.
SelectQuote offers a range of insurance products, including Medicare Advantage, life, home, and auto insurance, making it a versatile broker. The company is also expanding strongly into pharmacy fulfillment through the buildout of SelectRx. The market had a strong negative reaction to the results for the fiscal year ended 6/30/24 and guidance provided.
Net income missed an analyst's estimate, while revenue beat. The company's guidance for fiscal 2025 appears to have come up short of expectations by a healthy margin.
SelectQuote, Inc. (NYSE:SLQT ) Q4 2024 Earnings Conference Call September 13, 2024 8:30 AM ET Company Participants Matt Gunter - IR Tim Danker - CEO Ryan Clement - CFO Bob Grant - President Bill Grant - COO Conference Call Participants Ben Hendrix - RBC Capital Markets Patrick McCann - Noble Capital Markets Operator Hello, and welcome to SelectQuote's Fourth Quarter Earnings Conference Call. All lines have been placed on mute to prevent any background noise.